Filing Flows

Filing Flows › Bio-Rad Laboratories (BIO) › Q1 2025

Bio-Rad Laboratories (BIO) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 1, 2025

Bio-Rad Laboratories (BIO) reported revenue of $585M for the first quarter 2025 (Q1 2025), -4% from a year earlier and -12% from the quarter before. Operating margin was 4.0%, net earnings $64.0M (10.9% of revenue).

Revenue$585M
Year over year-4%
Quarter over quarter-12%
Operating margin4.0%
Net earnings$64.0M

Bio-Rad Laboratories, Q1 2025: revenue $585M (-4% year over year), operating margin 4.0%, net earnings $64.0M, operating cash flow $130M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$585M-12%-4%
Gross profit$306M-11%-6%
Operating profit$23.7M-59%-47%
Net earnings$64.0M—-83%
Operating cash flow$130M+5%+86%
Free cash flow$95.5M+17%+223%

What changed

Revenue was $585.4M in Q1 2025, down 4% year over year and down 12% from the previous quarter. Clinical Diagnostics was the largest line at 61% of revenue. Life Science lost $13.1M year over year (down 5%), 52% of the total change.

Gross margin was 52.3%, down 1.1 points from a year earlier. Operating profit was $23.7M, a 4.0% margin (down 3.3 points year over year). Operating expenses grew 0% against a revenue fall of 4%. The fastest-growing cost line was Research & development (+11%). Net earnings were $64.0M, down 83% year over year. The effective tax rate was 23.3%. Non-operating items added $59.7M, 72% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $129.9M (up 86% year over year), 203% of net earnings. Non-cash charges added back $15.3M of share-based compensation. Working capital and other items added $50.6M. Capital expenditures of $34.4M left free cash flow of $95.5M.

Questions

What was Bio-Rad Laboratories' revenue in the first quarter 2025?

Bio-Rad Laboratories (BIO) reported revenue of $585M for the first quarter 2025 (Q1 2025), -4% from a year earlier and -12% from the quarter before.

Was Bio-Rad Laboratories profitable in the first quarter 2025?

Operating profit was $23.7M (4.0% of revenue) and net earnings $64.0M.

Open the interactive Sankey →

Source: Bio-Rad Laboratories 10-Q on SEC EDGAR.